搜尋結果
Dosage/Direction for Use. IA inj only. Synvisc OA of the knee Three 2 mL inj in the knee, 1 wk apart. Max: 6 inj w/in 6 mth, w/ min 4 wk between treatment regimens. OA of the hip, ankle, shoulder Initially one 2 mL in the knee inj. A 2nd 2 mL inj may be given 1-3 mth after the 1st inj if adequate symptomatic relief is not achieved.
2021年3月9日 · Haematologists from the University of Hong Kong (HKU) have reported initial success with chimeric antigen receptor (CAR) T-cell therapy, treating the first patient in Hong Kong in May 2020 in a global lymphoma trial and another leukaemia patient in October 2020 in
Contents. Per tab Dihydrocodeine bitartrate 5 mg, guaifenesin 50 mg, DL-methylephedrine HCl 17.5 mg, chlorpheniramine maleate 1.5 mg. Per 100 mL syrup Dihydrocodeine bitartrate 50 mg, DL-methylephedrine HCl 131.25 mg, guaifenesin 375 mg, chlorpheniramine maleate 15 mg.
Budenofalk rectal foam 2 mg/actuation. Packing/Price. 14 actuation x 1's. Budenofalk (budesonide): Acute treatment of ulcerative colitis that is limited to the rectum & sigmoid colon.
Dosage/Direction for Use. SC Adult & adolescent ≥12 yr Severe eosinophilic asthma 100 mg once every 4 wk. Adult CRSwNP 100 mg once every 4 wk. EGPA 300 mg once every 4 wk. HES 300 mg once every 4 wk. Click to view Nucala detailed prescribing information.
Dosage/Direction for Use. Tab Oedema Initially 1 tab once daily. HTN 1-2 tab daily as monotherapy or in combination w/ other antihypertensives. Inj Oedema Initially 1-2 amp once daily. HTN 2-4 amp daily alone or in combination w/ other antihypertensives.
Action. Description: Mechanism of Action: Diprophylline is a theophylline derivative which is used similarly to theophylline as a bronchodilator. Pharmacokinetics: Absorption: Rapidly absorbed from the GI tract. Distribution: Distributed into breast milk. Excretion: Mainly excreted unchanged in the urine.
